Debug Stats | ### Total Build Time: 45 ms 37.711 KB CONCEPT_NAME gt=12 ms Completed: 12 ms rowSize= 318 bytesCONCEPT_SOLR_HIT_STATS gt=0 Completed: 0 ms rowSize= 14 bytesCONCEPT_DEFINITION gt=0 Completed: 0 ms rowSize= 466 bytes- Skipping details on:
CONCEPT_SYNONYM gt=NONE 0 Completed: 0 ms rowSize= 0 bytes - Skipping details on:
CONCEPT_TEXT gt=NONE 0 Completed: 0 ms rowSize= 0 bytes CONCEPT_SEMANTIC_TYPE gt=0 Completed: 0 ms rowSize= 188 bytes- Skipping details on:
CONCEPT_NAMESPACE gt=NONE 0 Completed: 0 ms rowSize= 0 bytes CONCEPT_PARENTS gt=4 ms Completed: 4 ms rowSize= 556 bytesCONCEPT_CHILDREN gt=0 Completed: 0 ms rowSize= 8 bytesCONCEPT_ANCESTRAL_ROOTS gt=4 ms Completed: 4 ms rowSize= 5.427 KBCONCEPT_RELATIONSHIPS gt=18 ms Completed: 18 ms rowSize= 13.730 KBCONCEPT_GENES gt=5 ms Completed: 5 ms rowSize= 15.882 KBCONCEPT_XREFS gt=2 ms Completed: 2 ms rowSize= 1.145 KBCONCEPT_ANCILLARY gt=0 Completed: 0 ms rowSize= 14 bytes- Reload Stats
|
Relationships (28)
Relation Types: diso_to_chem : 14 diso_to_diso : 8 diso_to_gene : 4 diso_to_phen : 2
Relationships: none : 5 gene_associated_with_disease : 4 gene_product_malfunction_associated_with_disease : 2 isa : 3 mapped_to : 1 may_treat : 9 permuted_term_of : 1 related_to : 3 | |
DISO_to_PHEN | 88 | |
genetic aspects C0017399 | DISO_to_CHEM | 72 | |
Amino Acid Transport Systems, Basic C0949774 | DISO_to_PHEN | 57 | |
genetic aspects C0017399 | DISO_to_CHEM | 47 | |
Amino Acid Transport Systems, Basic C0949774 | DISO_to_CHEM | 33 | |
Amino Acid Transport Systems, Neutral C0969702 | DISO_to_CHEM | | may_treat |
.beta.,.beta.-Dimethylcysteine C0030817 | DISO_to_CHEM | | may_treat |
5,7-Diiod-8-chinolinol C0012341 | DISO_to_CHEM | | gene_product_malfunction_associated_with_disease |
B(0,+)-Type Amino Acid Transporter 1 C2986633 | DISO_to_CHEM | | may_treat |
IODOQUINOL 210 MG ORAL TABLET C0689225 | DISO_to_CHEM | | may_treat |
IODOQUINOL 25GM/BTL PWDR C0977883 | DISO_to_CHEM | | may_treat |
IODOQUINOL 3%/LANOLIN DERIVATIVES SHAMPOO C0977884 | DISO_to_CHEM | | may_treat |
IODOQUINOL 650 MG ORAL TABLET C0689226 | DISO_to_CHEM | | gene_product_malfunction_associated_with_disease |
Neutral and Basic Amino Acid Transport Protein rBAT C2986631 | DISO_to_CHEM | | may_treat |
PENICILLAMINE 125 MG ORAL CAPSULE C0689910 | DISO_to_CHEM | | may_treat |
PENICILLAMINE 250 MG ORAL CAPSULE C0689911 | DISO_to_CHEM | | may_treat |
PENICILLAMINE 250 MG ORAL TABLET, COATED C0689912 | DISO_to_DISO | | permuted_term_of |
CSNU C0010691 | DISO_to_DISO | | related_to |
CYSTINURIA, TYPE A C1857388 | DISO_to_DISO | | related_to |
CYSTINURIA, TYPE A/B C1857390 | DISO_to_DISO | | related_to |
CYSTINURIA, TYPE B C1857389 | DISO_to_DISO | | mapped_to |
Cystinuria type 1 C0268643 | DISO_to_DISO | | isa |
Cystinuria, type 2 C0268644 | DISO_to_DISO | | isa |
Cystinuria, type 3 C0268645 | DISO_to_DISO | | isa |
Hypercystinuria C0268646 | DISO_to_GENE | | gene_associated_with_disease |
SLC3A1 gene C1420191 |
|
Genes (5)
Species: human : 5 | |
Human | SLC7A9 | 11136 | solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9 | all carriers of a SLC7A9 mutation manifested cystinuria if their normal allele had non-wild type nucleotides in two or more of the identified polymorphic sites Mutations of SLC7A9 for Japanese cystinuria patients are different from those reported for European and American population a novel splice-acceptor site mutation in the SLC7A9 gene may have a role in cystinuria [case report] deletions in SLC7A9 in cystinuria in cystinuria, the detection rate for mutations in SLC7A9 in children was 25% in the SLC7A9 gene for non-type I chromosomes Title:New insights into cystinuria: 40 new mutations,genotype-phenotype correlation, and digenic inheritance causing partial phenotype.|Association:Not Found|Conclusion:Digenic inheritance is an exception (two of 164 families), with a limited contribution to the aminoaciduria values (partial phenotype) in cystinuria. Further mutational analysis could focus on one of the two genes (SLC3A1 preferentially for type I and SLC7A9 for type non-I probands), while for mixed probands analysis of both genes might be required, with priority given to SLC7A9. Title:Genetic variations of the SLC7A9 gene: alleledistribution of 13 polymorphic sites in German cystinuria patients and controls.|Association:Y|Conclusion:In summary, our results show that cystinuria is a complex disease which is not only caused by mutations in SLC7A9 and SLC3A1, but also influenced by other modifying factors such as variants in SLC7A9. Title:Mutation analysis of SLC7A9 in cystinuria patients in Sweden.|Association:Not Found|Conclusion:We conclude that SLC3A1 is still the major disease gene among Swedish cystinuria patients, with only a minor contribution of SLC7A9 mutations as the genetic basis of cystinuria. The absence of SLC3A1 and SLC7A9 mutations in a substantial proportion of the patients implies that mutations in parts of the genes that were not analyzed may be present, as well as large deletions that escape detection by the methods used. However, our results raise the question of whether other, as yet unknown genes, may also be involved in cystinuria. gene deletion , codon 423 in cystinuria, type non-1 Title:Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a newclassification.|Association:Not Found|Conclusion:Clinical data show that cystinuria is more severe in males than in females. The two types of cystinuria (A and B) had a similar outcome in this retrospective study, but the effect of the treatment could not be analyzed. Stone events do not correlate with amino acid urinary excretion. Renal function was clearly impaired in 17% of the patients. Title:The population-specific distribution and frequencies of genomic variants in the SLC3A1 and SLC7A9 genes and their application in molecular genetic testing of cystinuria|Association:Not Found|Conclusion:Generally, we could show that a stepwise analysis directed to the most common mutations in the two cystinuria genes is sufficient to detect variants in more than 75% of patients of European origin. The test consists of nine different PCR-based approaches and therefore represents a low-cost, reliable and timesaving diagnostic tool. SLC3A1 and SLC7A9 mutations may have roles in cystinuria The finding of SLC7A9 mutations in all three subtypes underscores the complex interactions between specific cystinuria genes and other factors influencing cystine excretion | Human | PREPL | 9581 | prolyl endopeptidase-like | Cystinuria, type I (HCS and 2p21del) Both contiguous gene syndromes show similar features such as cystinuria, growth impairment, and hypotonia | Human | SLC3A1 | 6519 | solute carrier family 3 (amino acid transporter heavy chain), member 1 | Click here to display 16 evidence detail records. | Human | SLC1A5 | 6510 | solute carrier family 1 (neutral amino acid transporter), member 5 | analysis of SLC1A5 mutations on 19q13 in cystinuria patients | Human | ARG1 | 383 | arginase 1 | Diaminoaciduria (arginuria, lysinuria, cystinuria, ornithinuria) |
|